Efficacy of different polypill combinations for primary and secondary cardiovascular disease prevention: a systematic review and meta-analysis
BackgroundCardiovascular disease is the leading cause of mortality and morbidity worldwide, and polypills have established efficacy in preventing poor outcomes. However, evidence on the optimal polypill combination is lacking. The objective of the study is to estimate the optimal polypill combinatio...
Saved in:
| Main Authors: | Habib Yazgi, Shivani Mattikalli, Brian Fang, Hannah Heselton, Paddy Ssentongo, Michael Farbaniec |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Cardiovascular Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2025.1558579/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-effectiveness of the CV-polypill strategy versus standard care for secondary cardiovascular prevention in Spain: an analysis based on the SECURE trialResearch in context
by: Thomas Gaziano, et al.
Published: (2025-08-01) -
Effect of a Cardiovascular Polypill on Poststroke Cognition Among Ghanaians: Secondary Analysis of a Randomized Clinical Trial
by: Fred Stephen Sarfo, et al.
Published: (2024-08-01) -
Effective polypill therapy in patients with hypertension and dyslipidemia
by: V. E. Oleynikov, et al.
Published: (2025-07-01) -
Biological, as opposed to classic antipsoriatic drug or apremilast, treatment mitigates the risk of death and cardiovascular disease in psoriasisResearch in context
by: Khalaf Kridin, et al.
Published: (2025-01-01) -
Metabolic syndrome with mortality and major adverse cardiovascular events in an elderly population
by: Shailendra Kumar Karn, et al.
Published: (2025-05-01)